RenDx® RUO Multiplex assay system
Using patented technology, based on surface enhanced resonance Raman scattering (SERRS), Renishaw Diagnostics has developed the RenDx® Multiplex Assay System, providing automated, multiplex, high throughput in vitro screening for clinical research into infectious disease. Based on a multiplex PCR approach, the system offers several advantages over traditional screening methods.
Renishaw Diagnostics has developed the RenDx Fungiplex assay to detect the most common causative agents of invasive fungal disease. In addition, our team are developing further assays that will aid in the detection of the most common bacterial and viral pathogens associated with gastroenteritis and infection of cerebrospinal fluid (CSF).
For research use only. Not for diagnostic purposes.